Iterum Therapeutics (NASDAQ:ITRM) Upgraded to Buy at HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Iterum Therapeutics plc (NASDAQ:ITRM – Free Report) – HC Wainwright issued their FY2028 EPS estimates for shares of Iterum Therapeutics in a note issued to investors on Wednesday, February 7th. HC Wainwright analyst E. Arce expects that the company will earn $0.16 per share for the year. HC Wainwright currently has a “Buy” rating and […]
Iterum Therapeutics plc (NASDAQ:ITRM – Get Free Report) Director Michael W. Dunne purchased 25,000 shares of the business’s stock in a transaction dated Friday, December 22nd. The shares were purchased at an average price of $1.40 per share, for a total transaction of $35,000.00. Following the acquisition, the director now owns 113,754 shares of the […]
The Dow Jones index closed higher by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Iterum Therapeutics plc (NASDAQ:ITRM – Get Free Report) Director Michael W. Dunne purchased 20,000 shares of Iterum Therapeutics stock in a transaction on Wednesday, November 22nd. The shares were acquired at an average cost of $2.03 per share, with a total value of $40,600.00. Following the completion of the transaction, the director now directly owns […]